Jason Paul Steik, Chief Clinical Officer at Pennant Group, Inc. (PNTG), sold 1,394 shares at $38.52 ($54K) on 2026-08-06, disclosed to the SEC on 2026-08-10.
Open-market sale of $54k PNTG by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.